Insider buying last 90 days
No open-market insider purchases were filed for BXP in the last 90 days.
From Form 4 filings, dated to when each was filed.
BXP declared a quarterly dividend of $0.70, payable 30 October to shareholders of record as of 30 September. Coverage this week also placed BXP alongside National Health Investors in a value comparison, while a separate overview piece recapped the stock's price, dividend history and analyst ratings without introducing new developments.
BXP closed at $62.43, down 1.5%, sitting between its 50-day average of $67.34 and 200-day average of $63.07, reflecting a mixed trend. The stock has fallen 10.8% over one month and 6.9% over three months, though it remains up 21.4% over six months and down 17.2% over the past year. The GekkoIndex reads 65, placing BXP in the Accumulation zone, down 2.1 over the last five readings. Price sits 30.5% below Gekko Fair Value of $89.85.
BXP next reports earnings on 27 October, 28 days away and inside a typical 20-trading-day holding window; its last report showed EPS of $1.76 against a $1.80 estimate, with a -1% reaction, and it has beaten estimates in 3 of the last 8 quarters, averaging a 4.2% absolute move on results. No insider, Congress or unusual options activity appears in the recent windows, though one billionaire holder is recorded. Seasonally, the next 20 trading days have averaged -1.3% over 5 years, rising in 2 of them. Analyst consensus among 16 firms stands at 7 buy and 9 hold ratings, with a consensus target of $76.35.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
BXP scores 2 supportive, 1 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed2 headwinds
Averages disagree
Close $62.43 sits between the 50-day ($67.34) and 200-day ($63.07) averages, or the averages disagree.
See the chart65, Accumulation
Reading 65 is in the Accumulation zone.
See the GekkoIndex30.5% below
Price is 30.5% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 28 days
Reports on Oct 27, 2026, 28 days away — inside a typical 20-trading-day hold.
See earnings−1.3% on average
From this point in the calendar, the next 20 trading days averaged −1.3% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
BXP closed at $62.43 on Sep 28, 2026, −17.2% over the past year, inside a 52-week range of $49.72 to $76.37.
Use the left and right arrow keys to read daily values.
Put BXP on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
BXP develops and owns high-quality Class A office properties in the United States. Its holdings are concentrated in five major urban centers: Boston, Los Angeles, New York, San Francisco, and Washington, D.C. The company is known for the scale of its portfolio, which includes 196 properties totaling 51.2 million square feet, with six currently under construction or major redevelopment.
The company is organized as a Real Estate Investment Trust, meaning it operates across the full lifecycle of its properties, from development and acquisition through ongoing management and operation. Its business centers on assembling and running a collection of primarily Class A office assets rather than specializing in a single stage of the real estate process.
Shares of BXP are listed on the NYSE under the ticker BXP.
BXP’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 65, in the Accumulation zone, down 2.1 points over five sessions.
Down 2.1 points over five sessions.
Reading for Sep 28, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 19 | +2.9% | +1.5% | ||
| Accumulation (current zone) | 235 | 0.0% | −1.0% | ||
| Neutral | 340 | +0.1% | +1.5% | ||
| Distribution | 31 | −0.7% | −0.7% | ||
| Selling | 0 | Not available | |||
Average BXP share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
BXP trades 30.5% below Gekko Fair Value of $89.85, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what BXP shares are worth, recalculated every trading day.
$89.85
Gekko Fair Value, Sep 29, 2026
30.5% Undervalued
No open-market insider purchases were filed for BXP, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for BXP in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in BXP were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
BXP has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds BXP.
BXP reports on Oct 27, 2026 (28 days away), and beat the EPS estimate in 3 of its last 8 reports.
Oct 27, 2026
28 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jan 27, 2026 | $1.76 est $1.80 | $877.1M est $861.2M | −1.0% |
| Oct 28, 2025 | $1.74 est $1.72 | $871.5M est $881.3M | −5.6% |
| Jul 29, 2025 | $1.71 est $1.67 | $868.5M est $858.7M | −4.6% |
| Apr 29, 2025 | $1.64 est $1.65 | $865.2M est $832.8M | −3.8% |
| Jan 28, 2025 | −$1.45 est $0.49 | $858.6M est $843.7M | −7.7% |
| Oct 29, 2024 | $1.81 est $1.81 | $859.2M est $834.6M | −5.3% |
| Jul 30, 2024 | $1.77 est $1.72 | $850.5M est $818.6M | −0.1% |
| Apr 30, 2024 | $1.73 est $1.73 | $839.4M est $816.6M | −5.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for BXP is $76.35, +22.3% from the last close, from 16 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 16 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 21 | Evercore ISI | $67 | +7.3% |
| Sep 17 | Scotiabank | $73 | +16.9% |
| Sep 9 | Truist Financial | $68 | +8.9% |
| Sep 8 | Barclays | $79 | +26.5% |
| Sep 1 | Wells Fargo | $82 | +31.3% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 29, BXP averaged −1.3% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −2.3% | 1 of 5 |
| Next 10 trading days | −1.7% | 2 of 5 |
| Next 15 trading days | −0.1% | 2 of 5 |
| Next 20 trading days | −1.3% | 2 of 5 |
| Next 30 trading days | −1.5% | 3 of 5 |
For scale, BXP’s typical 20-trading-day move in either direction is about 5.5%.
BXP’s market cap is $9.96B, with a P/E ratio of 34.1 and revenue of $3.19B over the last twelve months.
3 headlines about BXP from the past week, newest first, each linking to the publisher.
BXP’s market cap is $9.96B at the Sep 28, 2026 close of $62.43, with 159.7M shares outstanding. The shares trade on a P/E ratio of 34.1.
The consensus analyst 12-month price target for BXP is $76.35, +22.3% from the last close. Of the 16 firms that rated the stock in the last 90 days, 7 rate it a buy, 9 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate BXP is undervalued: the Sep 28, 2026 close of $62.43 is 30.5% below Gekko Fair Value of $89.85. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
BXP is expected to report on Oct 27, 2026 (28 days away). Analysts expect earnings of $0.52 per share on revenue of $886.5M. BXP beat the earnings estimate in 3 of its last 8 reports, moving 4.2% on average across the report.
BXP’s 52-week high is $76.37 and its 52-week low is $49.72; it closed at $62.43 on Sep 28, 2026, −17.2% over the past year. Over the last five years the shares peaked at $133.11 on Mar 29, 2022.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (gekkoindex and fair value), 1 as mixed (trend) and 2 as headwinds (earnings risk and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.